Brookfield Asset Management Inc. Amicus Therapeutics, Inc. Call Options Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Nov 16, 2022	BUY	$6.23 - $11.12 $826,721 - $1.48 Million	132,700 New	132,700 $1.43 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $577,521 - $1.03 Million	92,700 Added 231.75%	132,700 $1.43 Million
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $1.34 Million - $2.12 Million	-170,000 Reduced 80.95%	40,000 $378,000
Q3 2021 Nov 16, 2021	BUY	$8.74 - $11.84 $1.84 Million - $2.49 Million	210,000 New	210,000 $2.01 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.